Mary C Guttieri

Title: Innovations by Mary C Guttieri

Introduction

Mary C Guttieri is a notable inventor based in Myersville, MD (US). She has made significant contributions to the field of antiviral research, holding two patents that showcase her innovative spirit and dedication to public health.

Latest Patents

Her latest patents include "Antiviral Rift Valley Fever Virus Peptides and Methods of Use." This invention entails synthetic short peptides based on the Rift Valley Fever Virus (RVFV) fusion protein. The peptides serve as broad-spectrum antivirals, useful for both prophylactic and therapeutic treatment against infections by hemorrhagic fever viruses, including RVFV, Ebola Virus, and Andes Virus, as well as vesicular stomatitis virus. Another patent is titled "Antibodies Expressed in Insect Cells," which describes three vectors that facilitate the conversion of Fab fragments or single-chain Fv fragments into full-length antibody molecules. The methods for using these vectors and the resulting antibodies are also detailed in this patent.

Career Highlights

Mary Guttieri works for the US Government as represented by the Secretary of the Army. Her role involves significant research and development efforts aimed at combating viral infections and enhancing public health safety.

Collaborations

She has collaborated with esteemed colleagues such as Connie S Schmaljohn and Robert F Garry, contributing to a rich environment of innovation and scientific inquiry.

Conclusion

Mary C Guttieri's work exemplifies the impact of innovative research in the field of virology. Her patents not only advance scientific knowledge but also hold the potential to save lives through improved antiviral treatments.